Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study is to assess the safety of a bivalent vaccine of two new 6:2 influenza virus reassortants in healthy adults prior to the release of the trivalent vaccine (FluMist) containing them.
Epistemonikos ID: c2ce4351394ad5e1cb8a50844c73316c3612cb20
First added on: Mar 23, 2020